Professor Ric Arseneau MD is a clinical professor at the University of British Columbia in Vancouver, Canada, and a specialist in internal medicine with expertise in Myalgic Encephalomyelitis or Chronic Fatigue Syndrome (ME/ CFS), Fibromyalgia and Long COVID. He is interviewed today about ME/CFS by Dr Funmi Okunola MD.

REFERENCES

1. Walitt B, Singh K, LaMunion SR, Hallett M, Jacobson S, Chen K, Enose-Akahata Y, Apps R, Barb JJ, Bedard P, Brychta RJ. Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome. Nature Communications. 2024 Feb 21;15(1):907.

2 Project ECHO at the University of New Mexico

3 Dr Ric Arseneau Website

4. ME TV

5 "Family & Friends" - ME TV Video

6 2003 Canadian Consensus Criteria for ME/CFS

7 2016 Definition for Fibromyalgia (FM)

8 Vahratian A, Lin JM, Bertolli J, Unger ER. Myalgic encephalomyelitis/chronic fatigue syndrome in adults: United States, 2021–2022. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2023 Dec 1.

9 "Chronic Fatigue Syndrome More Common than Previous Estimates" - Medical News Dec 2023

10 Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD, Reeves WC, Lloyd A. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study.Bmj. 2006 Sep 14;333(7568):575.

Dr Amy Proal, Microbiologist, President and Chief Scientific Officer of Polybio discusses Long COVID in the context of other viral illnesses that lead to Chronic Post Viral Illness. This is part 2 of a 2 part series.

REFERENCES

1. Polybio

2. Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Frontiers in microbiology. 2021 Jun 23;12:698169.

Dr Amy Proal, Microbiologist, President and Chief Scientific Officer of Polybio discusses Long COVID in the context of other viral illnesses that lead to Chronic Post Viral Illness. This is part 1 of a 2 part series.

REFERENCES

Polybio

Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Frontiers in microbiology. 2021 Jun 23;12:698169.

Professor James Jackson PsyD is a licensed neuropsychologist and internationally renowned expert on Long Covid and its effects on cognitive and mental health functioning. He is a research professor of Medicine and Psychiatry at Vanderbilt, University School of Medicine Consortium in Nashville, Tennessee in the USA. He is interviewed by Dr Funmi Okunola about the psychological management of mental illness in Long COVID.

References

1. “Clearing the Fog from Surviving to Thriving with Long COVID – A Practical Guide”.

2. The Long COVID Handbook by Gez Medinger & Professor Danny Altmann

3.Dindo L, Van Liew JR, Arch JJ. Acceptance and commitment therapy: a

transdiagnostic behavioral intervention for mental health and medical

conditions. Neurotherapeutics. 2017 Jul 1;14(3):546-53.

4.REVERSE LC - Randomized trial Evaluating Baricitinib on pERSistent nEurologic and Cardiopulmonary Symptoms of Long COVID

5."Live Like You Were Dying" - lyrics

6.Field Of Dreams -Movie

7.GAD-7

8.The Hospital Anxiety & Depression Scale

9.The Impact of Events Scale Revised

10.Post Traumatic Stress Disorder Checklist

Professor James Jackson PsyD is a licensed neuropsychologist and internationally renowned expert on Long Covid and its effects on cognitive and mental health functioning. He is a research professor of Medicine and Psychiatry at Vanderbilt, University School of Medicine Consortium in Nashville, Tennessee in the USA. He is interviewed by Dr Funmi Okunola about the nature and rehabilitation of Brain Fog in Long COVID.

He is also author of “Clearing the Fog from Surviving to Thriving with Long COVID – A Practical Guide”.

REFERENCES

1. “Clearing the Fog from Surviving to Thriving with Long COVID – A Practical Guide”.

2. The Long COVID Handbook by Gez Medinger & Professor Danny Altmann

3. MoCa Test

4. Mini Mental State Exam

THIS PODCAST WAS RECORDED ON THE 17th JANUARY 2024

Professor David Cutler, the Otto Eckstein Professor of Applied Economics at Harvard University in the U.S.A., research associate at the National Bureau of Economic Research and a member of the National Academy of Medicine in the USA talks about the economic cost of Long COVID.

REFERENCES

1 Otto Eckstein

2 Cutler DM, Summers LH. The COVID-19 pandemic and the $16 trillion virus. Jama. 2020

Oct 20;324(15):1495-6.

3 Cutler DM. The economic cost of long COVID: an update. Publish Online July. 2022.

Dr Richard J. Baron MD - President and CEO of the American Board of Internal

Medicine and the American Board of Internal Medicine Foundation, talks to Dr Funmi

Okunola about how Primary Care needs to adapt to provide medical services for

Long COVID and other forms of chronic disease.

1. The Patient Centered Medical Home, History, Seven Core Features, Evidence and

Transformational Change – Published by the Robert Graham Center, 2007

2. Homer CJ, Baron RJ. How to scale up primary care transformation: what we know and what we need to know?. Journal of general internal medicine. 2010 Jun;25:625-9.

3. The Aspen Policy Strategy Institute

Dr Funmi Okunola MD interviews Professor Michelle Harkins MD – Professor of Medicine at

the School of Medicine at the University of New Mexico in the USA about how to diagnose Long COVID in Primary Care. Professor Harkins runs a Post COVID clinic and Project Echo telehealth program that provides real time education and case discussions for community health practitioners for the management of Long COVID in the community.

1. Pinto MD, Lambert N, Downs CA, Abrahim H, Hughes TD, Rahmani AM, Burton CW,

Chakraborty R. Antihistamines for postacute sequelae of SARS-CoV-2 infection.

The Journal for Nurse Practitioners. 2022 Mar 1;18(3):335-8.

2. Brennan CM, Nadella S, Zhao X, Dima RJ, Jordan-Martin N, Demestichas BR,

Kleeman SO, Ferrer M, von Gablenz EC, Mourikis N, Rubin ME. Oral

famotidine versus placebo in non-hospitalised patients with COVID-19: a

randomised, double-blind, data-intense, phase 2 clinical trial. Gut.

2022 May 1;71(5):879-88.

3. Tosato M, Calvani R, Picca A, Ciciarello F, Galluzzo V, Coelho-Júnior

HJ, Di Giorgio A, Di Mario C, Gervasoni J, Gremese E, Leone PM. Effects

of l-arginine plus vitamin C supplementation on physical performance,

endothelial function, and persistent fatigue in adults with long COVID: a

single-blind randomized controlled trial. Nutrients. 2022 Nov

23;14(23):4984.

4. O'Kelly B, Vidal L, McHugh T, Woo J, Avramovic G, Lambert JS. Safety and efficacy of

low dose naltrexone in a long covid cohort; an interventional pre-post study.

Brain, Behavior, & Immunity-Health. 2022 Oct 1;24:100485.